BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neamatallah M, El-Bendary M, Elalfy H, Besheer T, El-Maksoud MA, Elhammady D, Abed S, Elegezy M, Kandeel L, Eldeib D, Mousa N, Abd El-Hafeez M, El-Gilany AH, Esmat G. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients. Immunol Invest. 2020;49:462-476. [PMID: 31615295 DOI: 10.1080/08820139.2019.1673772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao LN, Zhou SH, Wang N, Zhang ST, Liu M. Association between the Genetic Polymorphisms of CCL2, CCL5, CCL8, CCR2, and CCR5 with Chronic Hepatitis C Virus Infection in the Chinese Han Population. Immunol Invest 2021;:1-16. [PMID: 33902378 DOI: 10.1080/08820139.2021.1916524] [Reference Citation Analysis]
2 Shoukat M, Ullah R, Javaid M, Anas M, Tariq M, Faryal R. Detection Of TLR-2 germ line variants as a risk for obesity in local Pakistani population. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.04.006] [Reference Citation Analysis]
3 El-Bendary M, Naemattalah M, Yassen A, Mousa N, Elhammady D, Sultan AM, Abdel-Wahab M. Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation. World J Transplant 2020; 10(6): 162-172 [PMID: 32742949 DOI: 10.5500/wjt.v10.i6.162] [Reference Citation Analysis]
4 Kamal A, Ramadan A, Sherief D, Hassan A, Nosair N, Mabrouk M, Habeeb E, Haydra T. Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients. Clin Exp Hepatol 2021;7:293-6. [PMID: 34712831 DOI: 10.5114/ceh.2021.109336] [Reference Citation Analysis]
5 Talaat RM, Elsharnoby S, Abdelkhalek MS, El-Shenawy SZ, Elmasry S. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis. Immunol Invest 2021;:1-17. [PMID: 33445993 DOI: 10.1080/08820139.2020.1869251] [Reference Citation Analysis]
6 Moaaz M, Youssry S, Moaz A, Abdelrahman M. Study of Toll‑Like Receptor 4 Gene Polymorphisms in Colorectal Cancer: Correlation with Clinicopathological Features. Immunol Invest 2020;49:571-84. [PMID: 31996057 DOI: 10.1080/08820139.2020.1716787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Elbrolosy AM, Elabd NS, ElGedawy GA, Abozeid M, Abdelkreem M, Montaser B, Eed EM, Elhamouly MS. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients. Clin Exp Med 2022. [PMID: 35119591 DOI: 10.1007/s10238-022-00792-6] [Reference Citation Analysis]
8 Farid K, Elalfy H, Abo El-Khair SM, Elgamal H, Besheer T, Elmokadem A, Shabana W, Abed S, Elegezy M, El-Khalek AA, El-Morsy A, Negm A, Elsamanoudy AZ, El Deek B, Amer T, El-Bendary M. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients. Expert Rev Gastroenterol Hepatol 2020;14:1203-14. [PMID: 32933325 DOI: 10.1080/17474124.2020.1823215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Tian A, Li Y, Fan H, Hu P, Xu R, Yuan H, Cai J, Zhang W, Yue M, Li J, Dong C, Zhu C. Association of Elongation Factor Tu GTP-binding Domain-containing 2 Gene (EFTUD2) Polymorphism with the Risk of Hepatitis B Virus Infection. Immunol Invest 2021;:1-13. [PMID: 34436958 DOI: 10.1080/08820139.2021.1970763] [Reference Citation Analysis]
10 Neamatallah M, Serria MS, El‐bendary M, El‐gilany A, Alhawarey A, Abed S, Setate YA, Ammar OA. Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome. Br J Biomed Sci 2022;79:10237. [DOI: 10.3389/bjbs.2021.10237] [Reference Citation Analysis]
11 Zaidane I, Ouladlahsen A, Bensghir R, Chihab H, Jadid FZ, Fɩhry RE, Baba H, Filali KME, Oudghiri M, Wakrim L, Benjelloun S, Ezzikouri S. An assessment of toll-like receptor 7 and 8 gene polymorphisms with susceptibility to HIV-1 infection, AIDS development and response to antiretroviral therapy. Immunol Lett 2020;227:88-95. [PMID: 32888973 DOI: 10.1016/j.imlet.2020.08.008] [Reference Citation Analysis]
12 Ezzat R, Eltabbakh M, El Kassas M. Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures. World J Gastrointest Oncol 2021; 13(12): 1919-1938 [DOI: 10.4251/wjgo.v13.i12.1919] [Reference Citation Analysis]
13 Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst 2020;32:5. [PMID: 32372179 DOI: 10.1186/s43046-020-0016-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
14 Xu Y, Xue W, Gao H, Cui J, Zhao L, You C. Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status. PeerJ 2022;10:e13335. [DOI: 10.7717/peerj.13335] [Reference Citation Analysis]
15 Man SM, Jenkins BJ. Context-dependent functions of pattern recognition receptors in cancer. Nat Rev Cancer 2022. [PMID: 35355007 DOI: 10.1038/s41568-022-00462-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yengo CK, Torimiro J, Kowo M, Lebon PA, Tiedeu BA, Luma H, Njoya O, Rowland-Jones S, Yindom LM. Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon. Heliyon 2020;6:e05232. [PMID: 33102855 DOI: 10.1016/j.heliyon.2020.e05232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gao Y, Nepal N, Jin SZ. Toll-like receptors and hepatitis C virus infection. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00155-7. [PMID: 34419367 DOI: 10.1016/j.hbpd.2021.07.011] [Reference Citation Analysis]